Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain - PubMed (original) (raw)
Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain
E Puré et al. J Exp Med. 1990.
Abstract
Two prior studies with a small number of T cell lines have shown that the presentation of native protein antigens by epidermal Langerhans cells (LC) is regulated. When freshly isolated, LC are efficient antigen-presenting cells (APC), but after a period of culture LC are inefficient or even inactive. The deficit in culture seems to be a selective loss in antigen processing, since cultured LC are otherwise rich in major histocompatibility complex (MHC) class II products and are active APC for alloantigens and mitogens, which do not require processing. We have extended the analysis by studying presentation to bulk populations of primed lymph node and a T-T hybrid. Only freshly isolated LC can be pulsed with the protein antigens myoglobin and conalbumin, but once pulsed, antigen is retained in an immunogenic form for at least 2 d. The acquisition of antigen, presumably as MHC-peptide complexes, is inhibited if the fresh LC are exposed to foreign protein in the presence of chloroquine or cycloheximide. The latter, in contrast, improves the efficacy of antigen pulsing in anti-Ig-stimulated B blasts. In additional studies of mechanism, we noted that both fresh and cultured LC endocytose similar amounts of an antigen, rhodamineovalbumin, into perinuclear granules. However, freshly isolated LC synthesize high levels class II MHC molecules and express higher amounts of the class II-associated invariant chain. Fresh LC are at least 5-10 times more active than many other cells types in the level of biosynthesis of MHC class II products. These findings provide a physiologic model in which newly synthesized MHC class II molecules appear to be the principal vehicle for effective antigen processing by APC of the dendritic cell lineage. Another APC, the B lymphoblast, does not appear to require newly synthesized MHC class II molecules for presentation.
Similar articles
- Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture.
Kämpgen E, Koch N, Koch F, Stöger P, Heufler C, Schuler G, Romani N. Kämpgen E, et al. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3014-8. doi: 10.1073/pnas.88.8.3014. Proc Natl Acad Sci U S A. 1991. PMID: 2014224 Free PMC article. - Biochemical properties of MHC class II molecules endogenously synthesized and expressed by mouse Langerhans cells.
Becker D, Reske-Kunz AB, Knop J, Reske K. Becker D, et al. Eur J Immunol. 1991 May;21(5):1213-20. doi: 10.1002/eji.1830210518. Eur J Immunol. 1991. PMID: 2037010 - Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM, Arnold PY, White GA, Nardella JP, Mannie MD. Patel DM, et al. J Immunol. 1999 Nov 15;163(10):5201-10. J Immunol. 1999. PMID: 10553040 - Antigen processing and presentation by epidermal Langerhans cells. Induction of immunity or unresponsiveness.
Cruz PD Jr, Bergstresser PR. Cruz PD Jr, et al. Dermatol Clin. 1990 Oct;8(4):633-47. Dermatol Clin. 1990. PMID: 1979019 Review. - [Langerhans cells and presentation of antigens].
Hanau D, Esposito-Farese ME, de la Salle H. Hanau D, et al. Pathol Biol (Paris). 1992 Feb;40(2):109-13. Pathol Biol (Paris). 1992. PMID: 1608651 Review. French.
Cited by
- Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.
Cho KJ, Ishido S, Eisenlohr LC, Roche PA. Cho KJ, et al. J Immunol. 2020 Mar 15;204(6):1621-1629. doi: 10.4049/jimmunol.1901234. Epub 2020 Jan 29. J Immunol. 2020. PMID: 31996461 Free PMC article. - Immunological cells and functions in Gaucher disease.
Pandey MK, Grabowski GA. Pandey MK, et al. Crit Rev Oncog. 2013;18(3):197-220. doi: 10.1615/critrevoncog.2013004503. Crit Rev Oncog. 2013. PMID: 23510064 Free PMC article. Review. - Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection.
Castro-Seoane R, Hummerich H, Sweeting T, Tattum MH, Linehan JM, Fernandez de Marco M, Brandner S, Collinge J, Klöhn PC. Castro-Seoane R, et al. PLoS Pathog. 2012 Feb;8(2):e1002538. doi: 10.1371/journal.ppat.1002538. Epub 2012 Feb 16. PLoS Pathog. 2012. PMID: 22359509 Free PMC article. - Circulating HLA-DR(+) natural killer cells have potent lytic ability and weak antigen-presenting cell function.
Burt BM, Plitas G, Nguyen HM, Stableford JA, Bamboat ZM, Dematteo RP. Burt BM, et al. Hum Immunol. 2008 Aug;69(8):469-74. doi: 10.1016/j.humimm.2008.06.009. Epub 2008 Jul 18. Hum Immunol. 2008. PMID: 18640163 Free PMC article. - Antigen processing and CD24 expression determine antigen presentation by splenic CD4+ and CD8+ dendritic cells.
Askew D, Harding CV. Askew D, et al. Immunology. 2008 Mar;123(3):447-55. doi: 10.1111/j.1365-2567.2007.02711.x. Epub 2007 Oct 19. Immunology. 2008. PMID: 17949418 Free PMC article.
References
- Nature. 1970 Aug 15;227(5259):680-5 - PubMed
- J Exp Med. 1990 Aug 1;172(2):631-40 - PubMed
- J Cell Biol. 1974 Nov;63(2 Pt 1):430-40 - PubMed
- Cell Immunol. 1976 Aug;25(2):137-51 - PubMed
- J Immunol. 1978 Nov;121(5):2005-13 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials